These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30936525)

  • 1. Enzymatic anti-CRISPRs improve the bacteriophage arsenal.
    Suresh SK; Murugan K; Sashital DG
    Nat Struct Mol Biol; 2019 Apr; 26(4):250-251. PubMed ID: 30936525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins.
    Zhu Y; Zhang F; Huang Z
    BMC Biol; 2018 Mar; 16(1):32. PubMed ID: 29554913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRISPR-cas system promotes antimicrobial resistance in Campylobacter jejuni.
    Shabbir MA; Wu Q; Shabbir MZ; Sajid A; Ahmed S; Sattar A; Tang Y; Li J; Maan MK; Hao H; Yuan Z
    Future Microbiol; 2018 Dec; 13():1757-1774. PubMed ID: 30526040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression.
    Wiegand T; Karambelkar S; Bondy-Denomy J; Wiedenheft B
    Annu Rev Microbiol; 2020 Sep; 74():21-37. PubMed ID: 32503371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins.
    Hynes AP; Rousseau GM; Agudelo D; Goulet A; Amigues B; Loehr J; Romero DA; Fremaux C; Horvath P; Doyon Y; Cambillau C; Moineau S
    Nat Commun; 2018 Jul; 9(1):2919. PubMed ID: 30046034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cas9 in close-up.
    Garside EL; MacMillan AM
    Nat Biotechnol; 2014 Apr; 32(4):338-40. PubMed ID: 24714483
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.
    Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR
    Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition.
    Bradde S; Mora T; Walczak AM
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
    Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR Surveillance Turns Transposon Taxi.
    Wiegand T; Wiedenheft B
    CRISPR J; 2020 Feb; 3(1):10-12. PubMed ID: 32091255
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How bacteria control the CRISPR-Cas arsenal.
    Leon LM; Mendoza SD; Bondy-Denomy J
    Curr Opin Microbiol; 2018 Apr; 42():87-95. PubMed ID: 29169146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas systems for genome engineering and investigation.
    Concordet JP; Giovannangeli C
    Methods; 2017 May; 121-122():1-2. PubMed ID: 28645537
    [No Abstract]   [Full Text] [Related]  

  • 16. The Rcs stress response inversely controls surface and CRISPR-Cas adaptive immunity to discriminate plasmids and phages.
    Smith LM; Jackson SA; Malone LM; Ussher JE; Gardner PP; Fineran PC
    Nat Microbiol; 2021 Feb; 6(2):162-172. PubMed ID: 33398095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR adaptation in Escherichia coli subtypeI-E system.
    Kiro R; Goren MG; Yosef I; Qimron U
    Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas adaptation: insights into the mechanism of action.
    Amitai G; Sorek R
    Nat Rev Microbiol; 2016 Feb; 14(2):67-76. PubMed ID: 26751509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structure and function of CRISPR-Cas9].
    Nishimasu H
    Seikagaku; 2015 Dec; 87(6):686-92. PubMed ID: 26863746
    [No Abstract]   [Full Text] [Related]  

  • 20. CRISPRs and epigenome editing.
    Rusk N
    Nat Methods; 2014 Jan; 11(1):28. PubMed ID: 24524135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.